SavedAdd your journal

Journals / Ankara Üniversitesi Eczacılık Fakültesi Dergisi / 2020 / Cilt: 44 - Sayı: 2

RECENT DEVELOPMENTS ON PROLIPOSOME TECHNOLOGY AND APPLICATIONS

PROLİPOZOM TEKNOLOJİSİNDEKİ GÜNCEL GELİŞMELER VE UYGULAMALAR

Zerrin SEZGİN BAYINDIR
Nadir DERELİ
Pages
308–333
Publication Date
2020-05-31
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Within the scope of this review, scientific researches about proliposomal drug delivery systems and their applications were presented by searching academic databases.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Liposomes are the most promising and feasible carriers among other drug delivery systems.
📊
Key Findings & Data:In order to overcome these problems, proliposomal systems were developed in 1986.
💡
Conclusion & Impact:Within the scope of this review, scientific researches about proliposomal drug delivery systems and their applications were presented by searching academic databases.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:drug delivery systems · liposome · proliposomes

Abstract

Objective: Liposomes are the most promising and feasible carriers among other drug delivery systems. However, physical and chemical stability problems of liposomes limit their use. In order to overcome these problems, proliposomal systems were developed in 1986. Within the scope of this review, scientific researches about proliposomal drug delivery systems and their applications were presented by searching academic databases.

Özet

Amaç: Lipozomlar, ilaç taşıyıcı sistemler arasında en umut verici ve uygulanabilir olanıdır. Ancak, lipozomların fiziksel ve kimyasal stabilite problemleri kullanımlarını sınırlamaktadır. Bu problemlerin üstesinden gelmek için 1986 yılında prolipozomal sistemler geliştirilmiştir. Bu derleme kapsamında prolipozomal ilaç taşıyıcı sistemler ve uygulamaları ile ilgili yapılmış olan bilimsel araştırmalar akademik veri tabanları taranarak sunulmuştur.

🔖

Cite This Article

BAYINDIR, Z. S., DERELİ, N. (2020). RECENT DEVELOPMENTS ON PROLIPOSOME TECHNOLOGY AND APPLICATIONS. Ankara Üniversitesi Eczacılık Fakültesi Dergisi, Cilt: 44 - Sayı: 2, 308–333. https://ajindex.com/articles/83266

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Kumara, B.C., Parthiban, S., Senthil kumar, G.P., Tamiz Mani, T. (2015). Proliposome: A novel approach to carrier drug delivery system. International Journal of Biopharmaceutics, 6(2), 98-106 2. Shaji, J., & Bhatia, V. (2013). Proliposomes: A brief overview of novel delivery system. Int J Pharm Biosci, 4, 150-160. 3. Sezgin Bayindir, Z., &Yuksel, N. (2015). Provesicles as novel drug delivery systems. Current Pharmaceutical Biotechnology, 16(4), 344-364 4. Moreira, A. R. S. (2015). Development of proliposomes as a vehicle to deliver new molecules with antitumor activity. Faculty of Medicine of University of Porto, Portugal. 5. Nekkanti, V., Venkatesan, N., Betageri, G. (2015). Proliposomes for oral delivery: progress and challenges. Current Pharmaceutical Biotechnology, 16(4), 303-312. 6. Veerapu, G., Gangadharappa, H. V., Nagashubba, B., Balamuralidhara, V. (2014). Review on novel carrier system: liposomes and proliposomes. Drug Delivery Letters, 4(2), 96-109 7. Manani, H., Prajapati, B., Patel, R. (2016). Review of Preliposomes as novel drug delivery system. The Pharma Innovation, 4(3), 61-67 8. Sun, C., Wang, J., Liu, J., Qui, L., Zhang, W., Zhang, L. (2013). Liquid proliposomes of nimodipine drug delivery system: preparation, characterization, and pharmacokinetics. AAPS Pharmscitech, 14(1), 332-338. 9. Patel, G. M., Shelat, P. K., Lalwani, A. N. (2016). QbD based development of proliposome of lopinavir for improved oral bioavailability. European Journal of Pharmaceutical Sciences, 108, 50-61. 10. Xu, H., He, L., Nie, S., Guan, J., Zhang, X., Yang, X., Pan, W. (2009). Optimized preparation of vincopocetine proliposomes by a novel method and in vivo evaluation of its pharmacokinetics in New Zealand rabbits. Journal of Controlled Release, 140(1), 61-68. 11. Janga, K. Y., Jukanti, R., Velpula, A., Sunkavalli, S., Bandari, S., Kandadi, P., Veerareddy, P. R. (2012). Bioavailability enhancement of zaleplon via proliposomes: Role of surface charge. European Journal of Pharmaceutics and Biopharmaceutics, 80(2), 347-357. 12. Yanamandra, S., Venkatesan, N., Kadajji, V. G., Wang, Z., Issar, M., Betageri, G. V. (2014). Proliposomes as drug delivery system to decrease the hepatic first-pass metabolism: case study using a model drug. European Journal of Pharmaceutical Sciences, 64, 26-36 13. Deshmukh, D., Revis, W. R., Betageri G. V. (2008). Improved delivery of cromolyn from oral proliposomal beads. International Journal of Pharmaceutics, 358(1), 128-136. 14. Wang